Vadim Gurvich

Find an error

Name:
Organization: University of Minnesota
Department:
Title:
Co-reporter:Christopher J. Stenland, Lev G. Lis, Frederick J. Schendel, Nicholas J. Hahn, Mary A. Smart, Amy L. Miller, Marc G. von Keitz, and Vadim J. Gurvich
Organic Process Research & Development 2013 Volume 17(Issue 2) pp:265-272
Publication Date(Web):January 17, 2013
DOI:10.1021/op3003294
A scalable and reliable manufacturing process for nikkomycin Z HCl on a scale of 170 g has been developed and optimized. The process is characterized by a 2.3 g/L fermentation yield, 79% purification yield, and >98% relative purity of the final product. This method is suitable for further scale-up and cGMP production. The Streptomyces tendae ΔNikQ strain developed during the course of this study is superior to any previously reported strain in terms of higher yield and purity of nikkomycin Z.
Co-reporter:Lev. G. Lis, Mary A. Smart, Anna Luchniak, Mohan L. Gupta Jr., and Vadim J. Gurvich
ACS Medicinal Chemistry Letters 2012 Volume 3(Issue 9) pp:745
Publication Date(Web):July 30, 2012
DOI:10.1021/ml300149z
A biotinylated paclitaxel derivative with an extra-long chain (LC-LC-biotin) spacer arm was synthesized using an improved synthetic reaction sequence. The biotinylated paclitaxel analogue retained excellent microtubule stabilizing activity in vitro. Furthermore, it was shown that this analogue can simultaneously engage streptavidin and the binding site on microtubules, making it suitable for localization studies or for the attachment of paclitaxel to solid substrates via a streptavidin linkage.Keywords: biotin; biotinylated; paclitaxel; taxol
Co-reporter:Huzaifa S. Rangwala;John W. Giraldes;Vadim J. Gurvich
Journal of Labelled Compounds and Radiopharmaceuticals 2011 Volume 54( Issue 6) pp:340-343
Publication Date(Web):
DOI:10.1002/jlcr.1872

Abstract

[2-13C]-5-Fluoropyrimidine-2,4(1H,3H)-dione ([2-13C]-5-fluorouracil or [2-13C]-5-FU) is a potential diagnostic agent for measuring 5-FU-induced toxicity in cancer patients. It was prepared and purified with isotopic and chemical purity of>99% on a multigram scale in a two-step synthesis from [13C]-urea. Preparative separation of [2-13C]-FU and [2-13C]-uracil was carried out by automated medium pressure silica gel column chromatography. The method is applicable to a broader range of 5-FU isotopic analogs derived from labeled uracil. Copyright © 2011 John Wiley & Sons, Ltd.

Co-reporter:Vadim J. Gurvich, Stephen R. Byrn
Drug Discovery Today (October 2013) Volume 18(Issues 19–20) pp:916-921
Publication Date(Web):1 October 2013
DOI:10.1016/j.drudis.2013.05.014
•Academic partnership model for supporting and coordinating academic preclinical development.•Model for providing clinical supplies for academic clinical research.•Providing academic translational centers with access to infrastructure for developing clinical candidates.The strategic goal of academic translational research is to accelerate translational science through the improvement and development of resources for moving discoveries across translational barriers through ‘first in humans’ studies. To achieve this goal, access to drug discovery resources and preclinical IND-enabling infrastructure is crucial. One potential approach of research institutions for coordinating preclinical development, based on a model from the National Institute for Pharmaceutical Technology and Education (NIPTE), can provide academic translational and medical centers with access to a wide variety of enabling infrastructure for developing small molecule clinical candidates in an efficient, cost-effective manner.
14-O-phosphonooxymethyltriptolide dibenzyl ester
TRIPTOLIDE(PG490)
TRIPTONIDE
(13aR)-2,3,5,6-tetramethoxy-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline